Collegium Pharmaceutical
COLL
#6619
Rank
โ‚น75.18 B
Marketcap
โ‚น2,420
Share price
1.49%
Change (1 day)
-39.74%
Change (1 year)

Earnings for Collegium Pharmaceutical (COLL)

Earnings in 2026 (TTM): โ‚น11.00 Billion

According to Collegium Pharmaceutical 's latest financial reports the company's current earnings are โ‚น0.81 Billion. In 2025 the company made an earning of โ‚น16.32 Billion, an increase over its 2024 earnings that were of โ‚น16.09 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Collegium Pharmaceutical from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น11.00 B-32.58%
2025 โ‚น16.32 B1.38%
2024 โ‚น16.09 B8.47%
2023 โ‚น14.84 B362.88%
2022 โ‚น3.20 B94.82%
2021 โ‚น1.64 B-68.76%
2020 โ‚น5.26 B-358.85%
2019 -โ‚น2.04 Billion14.82%
2018 -โ‚น1.78 Billion-74.68%
2017 -โ‚น7.01 Billion-20.23%
2016 -โ‚น8.78 Billion250.85%
2015 -โ‚น2.51 Billion51.81%
2014 -โ‚น1.65 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
United Therapeutics
UTHR
โ‚น141.80 B 1,179.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-โ‚น1.41 Billion-112.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
โ‚น47.82 B 331.56%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
KemPharm
KMPH
-โ‚น3.91 Billion-135.28%๐Ÿ‡บ๐Ÿ‡ธ USA